Interpace Biosciences Inc (NASDAQ:IDXG)

4.08
Delayed Data
As of Oct 23
 +0.375 / +10.12%
Today’s Change
2.57
Today|||52-Week Range
11.00
-18.40%
Year-to-Date
SECTOR
Health Services
INDUSTRY
Services to the Health Industry
MARKET CAP
$16.9M

Company Description

Interpace Biosciences, Inc. operates as an bioinformatics company, which engages in the development and commercialization of molecular diagnostic test and pathology services. It offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion molecular test that can aid in pancreatic cyst diagnosis and pancreatic cancer risk assessment; ThyGenX and PathFinderTG which assesses thyroid nodules for risk of malignancy; and ThyraMIR, which assesses thyroid nodules for risk of malignancy utilizing a proprietary gene expression assay. The company was founded by John P. Dugan in 1987 and is headquartered in Parsippany, NJ.

Contact Information

Interpace Biosciences, Inc.
Morris Corporate Center 1
Parsippany New Jersey 07054
P:(855) 776-6419
Investor Relations:

Employees

Shareholders

Mutual fund holders3.12%
Other institutional17.37%
Individual stakeholders0.83%

Top Executives

Jack E. StoverPresident, Chief Executive Officer & Director
Fred S. KnechtelChief Financial Officer, Secretary & Treasurer
Sara A. JacksonVice President-Clinical Development
Sydney D. FinkelsteinChief Scientific Officer
Alidad MireskandariSenior Vice President-Business Development